REGENERON PHARMACEUTICALS, INC. reports

Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
Tarrytown, NY
SEC filing record 1 source field available
Fiscal year end
31 December
REGENERON PHARMACEUTICALS, INC. has filed 2,452 SEC EDGAR filings since 26 Jul 1995

SEC filing history

Showing 326-350 of 1,000 matching filings.

Per page
25
Current page
14
4

OWNERSHIP DOCUMENT

Filing date
12 Sep 2023
Reporting date
08 Sep 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
4

OWNERSHIP DOCUMENT

Filing date
12 Sep 2023
Reporting date
08 Sep 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
3

OWNERSHIP DOCUMENT

Filing date
12 Sep 2023
Reporting date
08 Sep 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
3

OWNERSHIP DOCUMENT

Filing date
12 Sep 2023
Reporting date
08 Sep 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K/A File 000-19034

FORM 8-K/A

Filing date
08 Sep 2023
Reporting date
09 Jun 2023
Next action
Verify source filing
SC TO-T/A

SC TO-T/A

Filing date
08 Sep 2023
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
06 Sep 2023
Reporting date
01 Sep 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
144 File 000-19034

144 filing

Filing date
01 Sep 2023
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
25 Aug 2023
Reporting date
23 Aug 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
25 Aug 2023
Reporting date
23 Aug 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
25 Aug 2023
Reporting date
23 Aug 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
25 Aug 2023
Reporting date
23 Aug 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
SC TO-T

SC TO-T

Filing date
25 Aug 2023
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
144 File 000-19034

144 filing

Filing date
24 Aug 2023
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
144 File 000-19034

144 filing

Filing date
23 Aug 2023
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
144 File 000-19034

144 filing

Filing date
23 Aug 2023
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
23 Aug 2023
Reporting date
21 Aug 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
23 Aug 2023
Reporting date
21 Aug 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
144 File 000-19034

144 filing

Filing date
22 Aug 2023
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
144 File 000-19034

144 filing

Filing date
21 Aug 2023
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13D

SC 13D

Filing date
18 Aug 2023
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
11 Aug 2023
Reporting date
10 Aug 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
144 File 000-19034

144 filing

Filing date
10 Aug 2023
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC TO-C

SC TO-C

Filing date
09 Aug 2023
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .